advertisement

Oculus

11.15 Other drugs in relation to glaucoma (53)

Showing records 1 to 25

Display all abstracts in classification 11.15 Other drugs in relation to glaucoma

Search within classification 11.15 Other drugs in relation to glaucoma
82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Muhsen S
International Journal of Ophthalmology 2019; 12: 1567-1574
82844 In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
Zhang Y
Journal of Ophthalmology 2019; 2019: 7419571
82263 Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure
Baker JC
Drugs and Aging 2019; 36: 991-997
82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Groth SL
Ophthalmology 2019; 126: 1511-1516
82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Rabina G
European Journal of Ophthalmology 2019; 0: 1120672119874682
82451 Trabeculectomy with Ologen® implant and bevacizumab
Glandorf K
Ophthalmologe 2019; 0:
82583 A review of systemic medications that may modulate the risk of glaucoma
Wu A
Eye 2020; 34: 12-28
82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Sadowsky AJ
Ocular Immunology and Inflammation 2019; 0: 1-5
82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Lam J
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494
82740 Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study
Pappelis K
Investigative Ophthalmology and Visual Science 2019; 60: 4548-4555
82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Pecen PE
Ocular Immunology and Inflammation 2019; 0: 1-5
82583 A review of systemic medications that may modulate the risk of glaucoma
Khawaja AP
Eye 2020; 34: 12-28
82740 Association of Systemic Medication Exposure With Glaucoma Progression and Glaucoma Suspect Conversion in the Groningen Longitudinal Glaucoma Study
Loiselle AR
Investigative Ophthalmology and Visual Science 2019; 60: 4548-4555
82219 Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation
Pecen PE
Ocular Immunology and Inflammation 2019; 0: 1-5
82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Barequet D
European Journal of Ophthalmology 2019; 0: 1120672119874682
82844 In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery
Zhu S
Journal of Ophthalmology 2019; 2019: 7419571
82286 SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy
Albeiruti E
Ophthalmology 2019; 126: 1511-1516
82451 Trabeculectomy with Ologen® implant and bevacizumab
Lommatzsch C
Ophthalmologe 2019; 0:
82179 Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection
Luttrell I
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2489-2494
82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Compan J
International Journal of Ophthalmology 2019; 12: 1567-1574
82263 Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure
Fintelmann R
Drugs and Aging 2019; 36: 991-997
82377 Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
Mimouni M
European Journal of Ophthalmology 2019; 0: 1120672119874682
82583 A review of systemic medications that may modulate the risk of glaucoma
Pasquale LR
Eye 2020; 34: 12-28
82451 Trabeculectomy with Ologen® implant and bevacizumab
Heinz C
Ophthalmologe 2019; 0:
82667 Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma
Lai T
International Journal of Ophthalmology 2019; 12: 1567-1574

Issue 20-4

Select Issue


advertisement

WGW-2021